Fatal hemoptysis in a patient with breast cancer treated with bevacizumab and paclitaxel

Ann Oncol. 2008 Nov;19(11):1977-8. doi: 10.1093/annonc/mdn641. Epub 2008 Sep 18.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bevacizumab
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Fatal Outcome
  • Female
  • Hemoptysis / chemically induced*
  • Humans
  • Neoplasm Metastasis
  • Paclitaxel / administration & dosage
  • Paclitaxel / adverse effects

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Paclitaxel